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a b s t r a c t
We present a new strategy for the fabrication of artificial skeletal muscle tissue with functional mor-
phologies based on an innovative 3D bioprinting approach. The methodology is based on a microfluidic
printing head coupled to a co-axial needle extruder for high-resolution 3D bioprinting of hydrogel fibers
laden with muscle precursor cells (C2C12). To promote myogenic differentiation, we formulated a
tailored bioink with a photocurable semi-synthetic biopolymer (PEG-Fibrinogen) encapsulating cells into
3D constructs composed of aligned hydrogel fibers. After 3e5 days of culture, the encapsulated myo-
blasts started migrating and fusing, forming multinucleated myotubes within the 3D bioprinted fibers.
The obtained myotubes showed high degree of alignment along the direction of hydrogel fiber deposi-
tion, further revealing maturation, sarcomerogenesis, and functionality. Following subcutaneous im-
plantation in the back of immunocompromised mice, bioprinted constructs generated organized artificial
muscle tissue in vivo. Finally, we demonstrate that our microfluidic printing head allows to design three
dimensional multi-cellular assemblies with an exquisite compartmentalization of the encapsulated cells.
Our results demonstrate an enhanced myogenic differentiation with the formation of parallel aligned
long-range myotubes. The approach that we report here represents a robust and valid candidate for the
fabrication of macroscopic artificial muscle to scale up skeletal muscle tissue engineering for human
clinical application.
© 2017 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
In mammalians, myogenesis is a complex phenomenon starting
from the very first weeks of embryonic development. This process
involves mononucleated cellsdnamed myoblastsdthat progres-
sively fuse forming plurinucleated syncytiadnamed myotubes. As
development proceeds, myotubes undergo a maturation process.
They grow in size and eventually the actin-myosin based contrac-
tile apparatus is assembled, together with the neuromuscular and
myotendinous junctions [1].
Skeletal muscles can self-repair relatively small damages
resulting from tears, small lacerations, strains, or toxins via a three-
stage process that involves demolition, repair, and remodeling of
myotubes. However, skeletal muscle cannot restore significant tis-
sue loss that can arise after severe trauma, invasive surgeries, or
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degenerative diseases [2,3].
Due to the biological and architectural complexity of muscle
tissue, engineering an artificial muscle still represents a daunting
task. In the recent past, few strategies have been proposed to
generate skeletal muscle tissue in vitro [4e6] and in vivo [7,8]. In
most studies, researchers primarily focused on the obtainment of
highly oriented myotubes that could mirror the natural organiza-
tion of muscle fascicles, by inducing either a mechanicaldstatic or
dynamicdor electrical stimulation. These methods demonstrated
the possibility of obtaining highly oriented myofibers, but showed
limitations in terms of process scalability. In addition, the goal of
achieving a multicellular spatially organized structure, mimicking
the complexity of native muscle, has not been fully addressed.
Finally, most of these studies rely on bulk cell-laden hydrogels, that
hinder the formation of aligned myotubes, as it has been proved
that, in such conditions [7,9], muscle precursor cells create a chaotic
3D entangled network of myotubes similar to those obtained in 2D
cultures. Hence, it is of utmost importance to develop alternative
approaches for improved ex vivo fabrication of muscle tissue that
would ultimately be suitable for organ transplantation in vivo.
3D bioprinting has the potential to fabricate highly customizable
and highly organized structures that, in principle, could be used for
the assembly of an entire muscle [10e12]. This emerging bio-
fabrication technology relies on the simultaneous deposition of
cells and biomaterials in a layer-by-layer fashion, to form 3D well-
organized heterogeneous structures that can mirror relevant
complex biological architectures both physiologically and
morphologically. Thanks to these attractive features, 3D bioprinting
is rapidly becoming a first-choice technique for a broad set of tissue
engineering (TE) scenarios, including skeletal muscle tissue
reconstruction [13e15]. In these approaches, hydrogels containing
muscle precursor cells are deposited in combination with support
structures in thermoplasts (e.g., polycaprolactone [13,15], poly-
urethane [15]) and/or sacrificial materials (e.g., Pluronic F127 [14])
to achieve proper arrangement of cell-laden struts. It was noticed,
however, that the level of organization of differentiated muscle
precursor cellsdi.e., the formation of long-range multinucleated
myotubes, their degree of alignment, and the assembly of sarco-
meresdwas limited, most likely due to substrate mechanical
properties and matrix density issues.
Inspired by the native structural morphology of skeletal mus-
cles, we speculated that the spatial confinement of muscle pre-
cursor cells into highly aligned and compact 3D bioprinted
hydrogel fiber structures could lead to a better orientation of the
arising myotubes, thus mimicking the natural muscle morphology
and organization more closely. Building on such a premise, we
developed a 3D bioprinting strategy based on a custommicrofluidic
printing head coupled to a co-axial extruder. This system enables
high resolution multi-material and multi-cellular deposition by
simultaneously extruding different bioinks or by rapidly switching
from one bioink to another. In this report, we first demonstrate
that, within few days of in vitro culture following 3D bioprinting,
muscle precursor cells start to elongate and fuse, forming highly
aligned myotubes. This is followed by a thorough analysis of the
obtained artificial myo-structures in terms of myotube length and
orientation, fluorescence immunocytochemistry, and gene
expression of relevant myogenic differentiation markers. Then, we
demonstrate in vivo that the 3D bioprinted constructs outperform
control bulk-hydrogels in terms of myotube structural organization,
supporting the hypothesis that the simple geometrical confine-
ment exerted by 3D bioprinted hydrogel fibers promotes the
architectural organization of muscle precursors cells. Finally, we
exploit the microfluidic printing head to assemble 3D structures
containing spatially organized combinations of different cell types.
We demonstrate that, through the implementation of a
microfluidic platform as the printing head, it is possible to achieve a
level of accuracy that was previously unachievable in extrusion-
based systems.
2. Materials and methods
2.1. Materials
All chemicals were purchased from Sigma-Aldrich and used
without further purification unless otherwise stated. Sodium algi-
nate (ALG, Mw z 33 kDa) was a kind gift from FMC Biopolymers.
2.2. Synthesis of photocurable PEG-Fibrinogen
Photocurable PEG-Fibrinogen (PF) was synthesized according
to a previously published two-step synthetic route [16]. Fibrin-
ogen molecules were first cleaved into smaller fragments in a 70%
formic acid solution containing 17 mg/mL cyanogen bromide
(CNBr). After dialysis purification, these fragments were pre-
treated with Tris(2-carboxyethyl) phosphine hydrochloride
(TCEP, molar ratio TCEP/fibrinogen cysteines ¼ 68:1) in a 50 mM
PBS solution containing 8M urea to reduce disulfide bonds to thiol
groups and then reacted with PEG-diacrylate (Mw ¼ 20 kDa,
250 mg/mL) following a thiol-ene Michael addition. Thus, a pho-
tocurable semi-synthetic polymer was obtained, composed of
fibrinogen denatured fragments with covalently-attached PEG
side chains bringing a vinyl moiety at their extremities. After
purification, PF was redissolved, sterile filtered and stored
at "80 #C as a stock solution.
2.3. Bioink formulation
ALG stock solution was prepared at a concentration of 100 mg/
mL in HEPES 62.5 mM. In a typical bioink preparation, 400 mL of
ALG solution were mixed with 600 mL of freshly thawed PF stock
solution, leading to a final concentration of 8 mg/mL PF, 40 mg/mL
ALG. Irgacure 2959 (BASF) was then added as a radical photo-
initiator at a final concentration of 1 mg/mL.
The two biopolymersdPF and ALGdused for the formulation
of the bioink played different roles in the presented 3D bio-
printing experiments: ALG was used only as temporary tem-
plating material to allow a precise deposition of cell-laden
hydrogel fibers through a custom-built co-axial printing head,
simultaneously delivering the bioink and a cross-linking solution
of CaCl2, while PF, after UV curing, generated a covalently cross-
linked matrix into which embedded myoblast could spread and
differentiate.
The relative concentration of ALG and Caþ2 ions have been
optimized in previously published works [17,18] through a sys-
tematic screening to guarantee both a cell-friendly environment
and high accuracy and resolution of 3D-printed structures.
2.4. Bioink rheology
Steady and dynamic rheological characterization of the poly-
meric solutions was performed at 23 #C on an Anton Paar MCR-302
rheometer equipped with a cone-plate system (diameter ¼ 40 mm,
angle ¼ 1#).
The viscoelastic properties, storage modulus G0(u) and loss
modulus G00(u) were determined through small amplitude oscil-
lating shear flows at angular frequencies ranging from 10"1 to
102 rad/s. Strain sweep experiments were performed first to
determine the linear strain regime. Shear viscosity behavior of the
bioinks was evaluated by applying a shear rate from 0.01 to 100 s"1.
Both steady shear and dynamic measurements were carried out as
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a function of ageing time. PF solution, stored at !80 "C, was rapidly
thawed and brought to room temperature. Immediately after, it was
diluted with either HEPES buffer (PF group) or 10 wt% alginate in
HEPES (PF-ALG group) to a final concentration of 0.8 wt% (ALG
concentration 4 wt%) and gently stirred for 5 min. The solution was
then poured on the plate of the rheometer which was set at 23 "C,
and allowed to thermally equilibrate for 60 s prior to starting the
measurement. This time point was conventionally chosen as the
zero value for the ageing time.
2.5. Design and fabrication of the microfluidic printing head
The dispensing head was purposely designed to be compatible
with multi-material deposition and rapid switch among different
bioinks. The systemwas obtained by combining a microfluidic chip
bearing a Y-junction (2 inlets, 1 outlet) with a coaxial needle sys-
tem. The microfluidic device was fabricated by micro-milling,
engraving microfluidic channels into two 5-mm-thick poly-
carbonate sheets. After machining, the two sheets were sonicated
in isopropanol for 30min and then sealed with a hot press at 130 "C
for ca. 30 min. All channels weremilled with a 200# 200 mm cross-
section. The chip outlet was fluidically connected to the inner
needle (25 G) of the coaxial needle system, while the outer needle
(19 G) presented an independent side inlet and was mounted
coaxially with the inner needle.
A gantry system based on precision linear stages (PI miCos PL-S
series, controlled by Galil DMC-1840 motion controller) was pur-
posely assembled and positioned inside a Class II biological safety
cabinet. Themicrofluidic headwas coupled to themotorized gantry
system, and its inlets connected to microfluidic syringe pumps
(neMESYS low pressure, Cetoni GmbH) by autoclavable Teflon
tubing (ID 1/1600).
2.6. Fabrication of 3D bioprinted constructs
Bioink was laden with C2C12 myoblasts (ATCC) at a density in
the 1÷5# 107 cells/mL range and supplied to the inner needle of the
dispensing coaxial system, while the outer needle was fed with
calcium chloride solution (0.3 M). The printing speed, as well as the
flow rates of the bioink and crosslinking solutions were adjusted to
obtain hydrogel fibers z 250 mm in diameter (printing
speed¼ 180mm/min, Qbioink¼ 5 mL/min, QCa2þ ¼ 4.6 mL/min). For all
the experiments, the layer height was set to 120 mm, the distance
between hydrogel fibers in the X-Y plane to 50 mm, and a total of 7
layers were manufactured (corresponding to ca. 1.5 # 106 cells/
construct), with an aligned organization of fibers to mimic the
natural morphology of muscle tissue.
Bulk-hydrogel constructs were fabricated as a negative control
group by casting the bioink on a rectangular mold (approx. equal in
size to the 3D bioprinted constructs), followed by crosslinking with
0.3 M calcium chloride solution.
Constructs (both 3D bioprinted and bulk-hydrogel) were
crosslinked by low-dose UV irradiation (365 nm, 1.3 mW/cm2 for
5 min), washed with 25 mM HEPES buffer containing 20 mM EDTA
for 5 min, and finally forwarded to in vitro and in vivo experiments.
As a proof of concept, the fabrication of multi-cellular constructs
containing two different cell types was also carried out. Bioink was
laden with either C2C12 or BALB/3T3 (infected with GFP and
mOrange, respectively) at the same cell density of 2 # 107 cells/mL.
The two resulting cell-laden bioinks were fed through the two in-
lets of the Y-junction of the printing head at the same flow rate
(QC2C12 ¼ QBALB/3T3 ¼ 2.5 mL/min), and bioprinting process was
performed as above described.
2.7. Microcomputed tomography - mCT
Acquisition of 3D bioprinted morphologies was performed by
micro-computed tomography (mCT) on acellular specimens. Prior to
scanning, samples were partially dried in 50% ethanol for 5 min and
then dipped into sunflower oil to increase X-ray contrast. Scanning
was performed using an Xradia MicroXCT-400 with the following
parameters: 40 kV voltage, 10 W power, no filter material, 0.18"
rotation step in an angle interval of 184". Voxel size was
4.97 # 4.97 # 4.97 mm3. Image analysis and 3D reconstruction of
printed samples were performed with ImageJ software [19].
2.8. In vitro culture of 3D bioprinted constructs
3D bioprinted constructs were cultured up to 21 days in DMEM
(Gibco) supplemented with 10% heat-inactivated fetal bovine
serum (FBS, Gibco), 100 IU/mL penicillin and 100 mg/mL strepto-
mycin (Gibco) at 37 "C and 5% CO2 humid atmosphere. The same
conditions were also employed during in vitro culture of C2C12-
laden bulk-hydrogel constructs.
2.9. In vivo construct implantation
Following 7 days of in vitro culture, 3D bioprinted and bulk-
hydrogel constructs were implanted subcutaneously in the back
of immunocompromised mice. Two-month-old male SCID mice
(n ¼ 5) were anesthetized with a 1:1 mixture of ketamine (5 mg/
mL) and xylazine (1 mg/mL) at a dose of 10 mL/kg i.m. Following a
limited skin incision on the medial side of the back, dorsal muscle
was separated from the skin, the construct was carefully positioned
and skin closure was performed by non-absorbable 6-0 silk sutures
(Clinsilk). Mice were sacrificed at 28 days after implantation for
morphological analysis. All experiments involving animals were
conducted according to the protocols of good animal experimen-
tation under the Italian Health Minister approval n" 228/2015-PR.
2.10. Immunofluorescence
Following in vitro culture, 3D bioprinted and bulk-hydrogel
specimens were fixed in 2% PFA and processed for fluorescence
microscopy as previously described [20]. Conversely, constructs
explanted from SCID mice were embedded in O.C.T. and quickly
frozen in liquid nitrogen cooled isopentane for sectioning at a
thickness of 8 mm on a Leica cryostat. Sections were rehydrated in
PBS and permeabilized with 0.2% Triton X-100 in PBS for 30 min.
Sections were incubated with anti-Myosin Heavy Chain (MHC,
Clone MF20 DSHB, 1:2 titer) and rabbit anti-Laminin (LAM, Sigma-
Aldrich #L9393, 1:500) primary antibodies in blocking buffer (PBS
plus 0.2% Triton X-100 and 20% heat-inactivated goat serum) for 1
h at room temperature (RT). After several washes with PBS, sections
were incubated with anti-mouse FITC (Chemicon, 1:500) and anti-
rabbit Alexa488 (Molecular Probes, 1:500) secondary antibodies in
blocking buffer for 1 h at RT. Samples were counterstained with
DAPI to detect nuclei, washed 3 times with PBS, and mounted on
glass slides with Vectashield mounting medium (Vector Labora-
tories). Samples were imaged with a Nikon Eclipse TE2000 mi-
croscope equipped with a CoolSNAP MYO CCD camera
(Photometrix) and MetaMorph software.
2.11. Total RNA isolation and RT-qPCR analysis
Expression levels of myogenic genes were evaluated on 3D
bioprinted and bulk-hydrogel constructs following in vitro culture
by two-step Quantitative Reverse Transcription PCR (RT-qPCR).
Total RNA was extracted and isolated using TRI Reagent (Sigma-
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Aldrich). Extracted mRNA was quantified by spectrophotometric
technique (Tecan Infinite M200 Pro) and 1 mg of total RNA was
reverse-transcribed using High Capacity cDNA Reverse Transcrip-
tion Kit (Thermo Fisher Scientific) according to the manufacturer's
protocol. Quantitative PCR analysis was performed on 10 ng of
cDNA in a total reaction volume of 10 mL, using TaqMan Universal
MasterMix II (Thermo Fisher Scientific) and primers (TaqMan Gene
Expression Assay, Thermo Fisher Scientific) for the following genes:
mouse myogenic differentiation 1 (MyoD1, Mm00440387_m1),
sarcomeric actin (ACTA1, Mm00808218_g1), myogenin (MYOG,
Mm00446195_g1), and myosin heavy chain 2 (MYH2,
Mm01332564_m1). In order to identify the best housekeeping
gene, analysis of the expression levels of several candidate refer-
ence genes was performed. In particular, after verifying the stability
of hypoxanthine phosphoribosyltransferase (HPRT,
Mm01318747_g1), TATA-binding protein (TBP, Mm00446971_m1),
casein kinase 2 (Csnk2a2, Mm01243455_m1), adaptor related
protein complex 3 delta 1 subunit (AP3D1, Mm00475961_m1) and
peptidylprolyl isomerase A (PPIA, Mm02342429_g1) using geNorm
v.3.5 [21], AP3D1 was chosen as the endogenous control. All ex-
periments were performed in triplicate.
2.12. Image analysis
Image analysis was performed using ImageJ software. In
particular, the distribution of myotube length and orientation on
3D bioprinted constructs following in vitro culture was obtained
from immunofluorescence micrographs by manually skeletonizing
myotubes into polylines. Myotube length was obtained as the sum
of all the segments composing each polyline, while myotube
orientation was calculated as the weighted average of the angle
formed by each segment with the direction of hydrogel fiber
deposition (0!), weighted by its length.
Analysis of inter-myofiber space was performed on immuno-
stained explant tissue sections. Briefly, LAM staining was used to
extract the contours of each myotube and to create a mask for the
generation of binary images, to which Local Thickness and 3D Color
Inspector plugins were applied. Color-maps data were further pro-
cessed to generate a pixel-based distribution plot of inter-
myofibers spacing [22].
3. Results
3.1. Microfluidic printing head, bioink formulation and rheology
As an emerging biofabrication field, 3D bioprinting still presents
some criticalities. Two of the biggest challenges, which hamper the
progress in this field and its translation toward the clinical arena,
relate to i) the formulation of bioinks and ii) the possibility to
perform the deposition multi-material/cellular structures within a
single construct [23,24]. To address all of these challenges, we
employed a microfluidic bioprinting head (Fig. 1aec) featuring a
multi-inlet Y-junction feeding a co-axial needle. The system was
characterized by overall small dimensions of the channels
(200 " 200 mm cross-section, dead volume < 1.5 mL), compatible
with rapid composition switching. Furthermore, since the system
operated in a laminar regime (Re z 6 " 10#3 in our printing con-
ditions), deposition of hydrogel fibers with an exquisitely tailored
spatiotemporal composition could be performed.
The instantaneous gelation of the bioinks took place at the tip of
the inner needle, where the bioinks delivered from the microfluidic
device came into contact with the cross-linking solution supplied
through the external needle (Fig. 1c). This was achieved by
exploiting the property of alginate to undergo instantaneous
gelation when exposed to divalent calcium ions. Such
instantaneous gelation prevented hydrogel fibers from collapsing,
leading to extremely high accuracy and shape fidelity of the 3D
bioprinted structures [25] (see supplementary video of 3D
printing).
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.biomaterials.2017.03.026.
In this work, we chose to blend ALG with a semi-synthetic
biopolymer (PF), consisting of fibrinogen fragments with
covalently-attached PEG side chains bringing a vinyl moiety at their
ends.
A fundamental property of fibrinogen is its ability to self-
assemble into non-covalent networks, as in the first steps of
wound healing. While crucial from a biological point of view, this
phenomenon may represent an obstacle in the use of fibrinogen as
a biomaterial, in particular for 3D bioprinting applications. Indeed,
the presented 3D bioprinting method requires fluid solutions in
order to maintain resolution and shape fidelity constant during
printing. To assess whether PF still exhibited the tendency of
pristine fibrinogen to self-assemble, eventually giving rise to a gel, a
detailed rheological characterizationwas carried out: the evolution
of the storage (G0) and loss (G00) moduli for increasing ageing times
is reported in Fig. 2a. Already at early time points (0 and 3 min), the
presence of some degree of supramolecular organization was
confirmed by the analysis of G0 and G00 traces, with G00 being lower
than G0 at low shear rate values (i.e., the viscous region). At longer
ageing times, a clear tendency of PF chains to organize into a
network was reported. After 10 min a weak gel-like behavior was
evidenced, and for longer ageing times (20 min) the network
structure consolidated further, as witnessed by the enhanced sep-
aration between G0 and G00 traces. The gel could be categorized as a
weak one, since both G0 and G00 displayed a marked dependence on
the frequency [26]. This information is valuable, since it provides a
practical criterion for the timing and handling conditions of PF
solutions. The rheological data indicated that PF solutions had to be
used within the very few minutes after thawing.
The use of the above described microfluidic printing head relies
on the ionic gelling properties of alginate, meaning that PF must be
blended with alginate (PF-ALG). Therefore, characterization of PF-
ALG was performed in a similar fashion to verify whether the
addition of alginate attenuated the effects of ageing. Results are
reported in Fig. 2d, where data for pristine ALG have also been
included. The most relevant aspect is that the blend did not exhibit
any time dependent behavior, with G0 and G00 traces not changing
significantly on a time scale of 20 min. Furthermore, we studied the
possible occurrence of time dependent phenomena regarding vis-
cosity (h) and shear stress (t). Again, the analysis was carried out in
a comparative fashion by taking into consideration PF and the PF-
ALG blend. A pronounced shear thinning behavior as a function
of _g was observed in both cases (Fig. 2, b c, e, f). As a reference, we
also report the viscosity of a solution of pristine ALG (green circles
in Fig. 2e), the behavior of which was essentially Newtonian. The
most relevant difference between the two datasets was the time
invariant behavior of h and t for PF-ALG at _g values above 10 s#1,
while PF exhibited a quite pronounced dependence on the ageing
time in thewhole range of shear rate. By entering this value into the
shear stress vs. shear rate plot (Fig. 2f), it was possible to extrapo-
late a critical shear stress value ofz1.3 Pa above which the bioink
was substantially unaffected by ageing.
3.2. Optimization of 3D bioprinting process
The role of the microarchitecturedi.e., fiber orientation and
fiber-to-fiber distancedon the performance of bioprinted con-
structs has been addressed by relatively few works [27,28], while
the majority of the approaches still rely on the common alternating
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0e90! pattern as a volume-filling strategy. Although this archi-
tecture may be generally sufficient for most applications, the 3D
deposition of muscle precursor cells should take into account the
high degree of anisotropy of the target tissue (see Supplementary
Fig. S1).
For this reason, we chose to bettermimic the nativemorphology
of skeletal muscles by designing a toolpath for the deposition of
layers of aligned fibers. Compared to the common 0e90!, such an
architecture is less mechanically stiff as the number of junction
points among fibers belonging to adjacent layers is drastically
reduced. To account for such potential limitation, a careful opti-
mization of printing parameters was carried out. We restrained
from the common strategies used to improve the stability of
additively manufactured structures, and consisting in the deposi-
tion of either additional adhesion layersdgenerally at the begin-
ning of the printing processdor a perimetric shell to confine the
desired structure. Either of these strategies are not suitable for our
purpose, as they partially reduce the degree of biomimicry of the
engineered constructs. Instead, we managed to stabilize the
deposition of purely aligned fibers by i) minimizing the distance
among laying fibers in X-Y plane (down to ~ 50 mm) and ii) shifting
the fibers of each new layer, so that the center of each fiber fell mid-
way between the underlying fibers. Although not fully reaching
close cylinder packing configuration (i.e., honeycomb lattice with
kissing number¼ 6 and packing density¼ 0.9069), the contact area
among fibers was greatly augmented and specimens showed pro-
longed structural integrity and stability in culture medium after PF
photo-crosslinking (Fig. 3).
Another parameter that required careful optimization was the
cell density in the bioink (see Supplementary Fig. S2). In fact, to
undergo a rapid and efficient fusion and differentiation in 3D,
muscle precursor cells require intimate cell-to-cell contact within
the hydrogel [29]. We thus performed a series of experiments with
different cell densities in the 1÷5 # 107 cells/mL range, with best
performances achieved for a cell density ca. 2 # 107 cells/mL. At
lower cell densities (<2 # 107 cells/mL), myotube formation was
Fig. 1. 3D bioprinting set-up. a) Custom-built 3D printer equipped with fully programmable microfluidic pumps. b) Microfluidic printing head coupled to (c) coaxial extruder. d)
Diagram showing the procedure for the fabrication of covalently crosslinked 3D bioprinted PEG-Fibrinogen based scaffolds and the following ALG removal prior to undergo in vitro
culture.
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Fig. 2. Rheological studies. a-c) PF (0.8% w/w) d-f) PF (0.8% w/w) þ ALG (4% w/w) in 25 mM HEPES buffer at different ageing times as indicated in the graphs. a, d) Storage (G0 , filled
symbols) and loss (G00 , empty symbols) moduli. Shear rate dependencies: b, e) viscosity (h) c, f) shear stress (t). Curves were scaled along the vertical axes by the multiplying factors
indicated in graphs in a) and d).
Fig. 3. a) 3D bioprinted structure composed of unidirectional aligned PF hydrogel fibers. a) Macrograph of a 3D bioprinted construct into a 35 mm Petri dish. b) High
magnification optical micrograph of the construct; a schematic representation of fiber arrangement is reported in the inset. c) X-ray microtomographic scan of the sample in (a).
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hampered, most likely due to the increased distance between
neighboring cells. Higher cell densities (>3 ! 107 cells/mL), on the
contrary, led to the formation of unorganized cell clusters, that
hindered proper cell elongation and differentiation.
The last key parameter that influenced the number and quality
of myotubes was the hydrogel stiffness. It is well known that
myoblasts in vitro sense the substrate stiffness which, in turn, af-
fects cell differentiation and sarcomeric unit assembly [30]. In the
presented approach, after 3D bioprinting and UV-crosslinking, the
deposited hydrogel fibers were composed of an interpenetrating
polymer network (IPN) of ionically crosslinked ALG and chemically
crosslinked PF chains. The Young's modulus of such IPN system
(48 kPa) was well above the optimal range of substrate modulus for
myotube differentiation (8e11 kPa) [30,31], with the ionically
crosslinked ALG network contributing for the most part to the
overall stiffness. However, ALG network could be easily dis-
assembled by exposure to solutions containing calcium chelating
agents, such as EDTA (see Supplementary Fig. S3). Once optimized,
this process could be systematically used to control the stiffness of
the constructs and bring it to values more suitable for myotube
differentiation. We found that a good compromise between cell
viability, construct stability, and myotube differentiation was ob-
tained with 5 min washing in 20 mM EDTA solution.
3.3. In vitro culture of 3D bioprinted myostructure
We fabricated highly aligned hydrogel structures laden with
C2C12 at a concentration of 2 ! 107 cells/mL. In parallel, we pre-
pared PF bulk-hydrogels with the same myoblast cell density. Mi-
crographs confirmed that, within 24/48 h after polymerization,
bulk-hydrogels quickly undertook myogenic differentiation form-
ing a chaotic 3D entangled network of myotubes (Figs. S4a and b),
in agreement with already published data [7,32]. Similarly, myo-
blasts in the 3D bioprinted constructs showed a remarkable muscle
differentiation, albeit with a small delay. Differently frommyotubes
in the bulk-hydrogel, those in the printed constructs displayed a
striking parallel organization, accompanied by the expression of
MHC and LAM (a component of the basal lamina of muscle fibers),
as it naturally occurs in skeletal muscle (Figs. S4c and d). The
muscle differentiation process was monitored up to 21 days,
studying the 3D bioprinted myo-structure every 4 days by bright
field and immunofluorescence microscopy (Fig. 4). Micrographs
documented an increase in myotube number and length with
increasing culture time, and this was accompanied by an increase in
MHC expression. Since the initial days of culture, myoblasts started
migrating, spreading, differentiating and fusing, forming multinu-
cleated myotubes within the 3D bioprinted fibers. Interestingly,
muscle precursor cells elongated in the direction of fiber deposi-
tion, before fusing with adjacent cells. This may be rationalized as
polymeric chains orienting in the direction of flow upon extrusion,
and cells sensing an anisotropic surrounding matrix.
At late time points (12, 16 and 21 days after printing), myotubes
underwent sarcomerogenesis as revealed by higher magnification
immunofluorescence micrographs. At day 21, completely striated
myofibers were observed (Fig. 4ieo, white arrows). The assembly of
sarcomeres, besides being considered the gold standard marker of
advanced myotube maturation, guarantees their proper contractile
function (see supplementary video of spontaneous contracting
myostructures).
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.biomaterials.2017.03.026.
To gain a quantitative overview of the differentiation status of
C2C12 myoblasts, we analyzed the gene expression of relevant
myogenic differentiation markers (ACTA1, MyoD1, MYOG,
MYH2dFig. 5). Results further confirmed the muscle
differentiation progress in relation with culture time and with
myostructure maturation, with an exceptional expression of MYH2
that was approximately 5000 times higher than at day 0.
Finally, we evaluated the degree of myotube alignment and
length in muscle networks obtained in 3D bioprinted constructs.
These are two important parameters that influence the function-
ality of the engineered tissue. We thus analyzed a quite large region
(2000 ! 300 mm) of a 3D bioprinted construct after 15 days of
in vitro culture. Immunofluorescence analysis showed a strong
myogenic differentiation, as evidenced by multinuclear syncytia
formation and MHC expression (Fig. 6a and b). Quantitative image
analysis revealed a larger fraction of long myotubes in the range
300e400 mm (average myotube length ¼ 346 mm) with a highly
parallel orientation (>90%myotubes within ±10# deviation vs. fiber
printing direction, Fig. 6ced), confirming that 3D bioprinting rep-
resents an ideal approach for the fabrication of macroscopic arti-
ficial skeletal muscles.
3.4. In vivo grafting of 3D bioprinted myostructure
To study whether the 3D bioprinted structures have the po-
tential to mature into functional muscle tissue in vivo, we implan-
ted them subcutaneously on the back of immunocompromised
SCID mice (Fig. 6). In order to elute the ALG component, scaffolds
were pre-cultured in vitro for 7 days, a time period that is not
sufficient to obtain mature myotubes (Fig. 4), prior to in vivo im-
plantation. Similarly, we also implanted PF bulk-hydro-
geldcontaining C2C12 myogenic progenitors at a comparable
densitydto better assess the potential beneficial effect of 3D bio-
printing approach.
The implants were collected and analyzed 28 days after grafting,
macroscopically revealing the formation of a “pinkish” tissue like
structure (Fig. 7a,b). Histological analysis performed on bulk-
hydrogel and 3D bioprinted implants revealed the formation of
artificial muscle like tissue composed by MHC-positive myofibers
surrounded by LAM in both implant types (Fig. 7c,d,e,h). However,
3D bioprinted implants were characterized by a more pronounced
parallel orientation and organization, with a uniform size of muscle
fibers (Fig. 7e,h). In addition, they showed denser myofiber orga-
nization with reduced inter-fiber spacing (compare Fig. 7f,g with
Fig. 7i,j). Interestingly, 3D bioprinted hydrogel fibers were partially
degraded (Fig. 6d) after 28 days in vivo, and partially substituted by
the arising myofibers.
Finally, 3D bioprinted explants were further sectioned longitu-
dinally (Fig. 7k,m) to evaluate the myofiber differentiation status.
After 28 days in vivo, completely striated myofibers were observed,
confirming the advanced degree of myotube maturation.
3.5. Multi-cellular 3D bioprinting via microfluidic printing head
As a proof of concept, we tested the performance of our
microfluidic printing head in the fabrication of multi-cellular 3D
bioprinted scaffolds containing two different cell typesdnamely
C2C12 and BALB/3T3 (Fig. 8). The benefits of co-culturingmyoblasts
(C2C12) with fibroblasts (BALB/3T3) has been reported in the past,
demonstrating that fibroblasts support myoblast differentiation by
secreting extracellular matrix components and growth factors [33].
Fluorescence micrographs suggested that C2C12 and BALB/3T3
were finely compartmentalized within the deposited hydrogel fi-
bers and that the Janus flow pattern formed in the outlet channel of
the microfluidic printing head was perfectly retained following
gelation (Fig. 8b). Interestingly, after 5 days of culture, C2C12
started to spread and fuse, forming myotubes exclusively on the
side of the hydrogel fibers in which they were compartmentalized
(Fig. 8c).
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4. Discussion
Skeletal muscle tissue engineering represents an emerging field
that holds great promise for assembling artificial muscles to be
used for ex vivo studies and eventually for the replacement of
diseased or injured muscle tissue. To date, however, none of the
numerous strategies that have been proposed proved completely
satisfactory [34e36]. Although these methods were developed
with great expectations for their possible therapeutic applications,
so far the results achieved in vivo are scarce [37e39]. Mirroring the
natural structural organization of parallel-oriented myofibers has
been one of the major difficulties encountered. A number of
different approaches have demonstrated encouraging effect on
myostructure organization, promotingmuscle fibers alignment and
Fig. 4. Bright field and MHC immunofluorescence micrographs of 3D bioprinted C2C12 myogenic cells at different time points. a,b) Day 1 showing round shaped, MHC
negative C2C12 cells. c,d) Day 4 displaying myogenic differentiation besides MHC expression. e,f) Day 8 revealing increasing formation of myotubes expressing MHC; g-i) Day 12
presenting close packing of aligned myotubes. j-l) Day 16 showing a well-organized myostructure with the first evidence of sarcomere formation (white arrows) m-o) Day 21
revealing the progressive formation of myofibers and an outstanding sarcomeric organization. Nuclei were counterstained with DAPI.
M. Costantini et al. / Biomaterials 131 (2017) 98e110 105
maturation in a small scale in vitro [6,40,41]. However, preserving
the correct myo-architecture during in vivo engraftment still rep-
resents a challenge.
Furthermore, as many tissues and organs, skeletal muscle is not
assembled from a single cell type and needs blood vessel and
nerves for correct functioning. Thus, to further advance skeletal
Fig. 5. mRNA expression levels of selected myogenic differentiation markers measured by RT-qPCR for 3D bioprinted constructs at desired time points (7,21 days). Bar charts
depict fold change of expression levels normalized to day 0.
Fig. 6. Quantification of myotube alignment and length in muscle networks obtained in 3D bioprinted constructs after 15 days of in vitro culture. a) Tiled immunofluo-
rescence micrographs of a large region (300 ! 2000 mm) and b) high magnification of the ROI evidenced in (a). c) Myotube length distribution. d) Polar chart of myotube orientation,
with 0" corresponding to the printing direction.
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muscle tissue engineering, it is necessary to develop new tech-
nologies capable of fabricating 3D engineered constructs with ac-
curate spatial organization of different cell types.
Nowadays, additive manufacturing technologies are revolu-
tionizing all manufacturing fields, including tissue engineering
[42]. In particular, 3D bioprinting technologies hold great promise
Fig. 7. In vivo implantation of PF constructs on the back of immunocompromised SCID mice. a,b) Optical macrographs of the explants after 28 days of in vivo culture. c,d)
Immunofluorescence micrographs on explant cross-sections stained for MHC (in red) and LAM (in green). e,h) Magnification of the dotted areas in c,d) obtained from bulk-hydrogel
(e) and 3D bioprinted (h) explants. f,i) Color-calibrated maps of inter-myofiber spacing (di-fib) for bulk-hydrogel (f) and 3D bioprinted (i) explants. g,j) Distribution charts from (f,i). k)
Longitudinal cross-section of 3D bioprinted explant showing functional organization of MHC and LAM. l) MHC immunostaining reveals fully striated sarcomeric organization in
artificial muscle myofibers. m) Magnification of dotted area in (l) favoring sarcomeres identification (white arrows). (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
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for the rapid and cost-effective production of highly customized
and cellularized constructs. These technologies have characteristics
that are particularly suitable for the task of assembling in vitro
artificial muscles. In addition, they are in principle scalable and
have the potential to build human-sized myostructures [14,42,43].
However, the accuracy in cell deposition offered by these tech-
nologies is still far from that required to mimic the whole native
morphology of tissues/organs and, thus, limited tissue/organ
functionality can be recapitulated.
To bridge the gap between accessibility and performance, we
developed a new concept of extrusion-based bioprinting technique,
which implements a microfluidic control in the dispensation of the
bioink. An interesting feature offered by our extrusion system is
that the accuracy and printing quality are completely decoupled
from the rheological behavior of the extruded bioink. This means
that the composition of the deposited bioink can be freely tailored
by blending ALG with a vast selection of biopolymersdgenerally
photocurabledindependently from their rheological properties,
opening new routes for the deposition of value-added biopolymers
with non-ideal rheological properties [18]. Indeed, in this work we
report the successful 3D deposition of PEG-Fibrinogen, a non-easily
processable biomaterial. This represents a tremendous advantage,
as it has been demonstrated that fibrinogen-derived bio-
materialsdin addition to their biodegradable nature and non-
immunogenicitydsupport cell adhesion, spreading, and differen-
tiation of several cell lines including muscle progenitors
[7,16,32,44e47]. Moreover, the microfluidic printing head,
compatible with functional-graded (i.e., multi-material and/or
multi-cellular) additive manufacturing might represent an
enabling technology for future 4D printing strategies [48].
These features, combined with the tailored bioink composed of
PEG-Fibrinogen and alginate, allowed building myoconstructs with
different mesh and size bridling myogenic cells (C2C12) and fi-
broblasts (BALB/3T3) in precise constraints to guide myotube
alignment (Figs. 4 and 6, S1, S4). Although recent publications
explored 3D printing technology for skeletal muscle tissue engi-
neering [13,14], the results obtained were still unsatisfactory,
revealing a poor architectural organization in vitro and in vivo. On
the contrary, in this study we obtained a remarkable muscle
structuration not only at the morphological level, but also and
overall at the functional level, as the myostructures present sar-
comerogenesis and show full functionality (Fig. 4o and Supple-
mentary Video 2). The salient features of our strategy include: i) the
small diameter of the deposited fibers (ca. 200 mm vs. >400 mm
reported in other studies [13e15]) which better confine C2C12
myoblasts; ii) the inner grid structure composed of tightly packed
layers of unidirectionally oriented PF fibers; and iii) the formulation
of a unique bioink containing PEG-Fibrinogen, a semi-synthetic
polymer able to enhance myogenic differentiation. Hence, 3D bio-
printed myostructures were also implanted subcutaneously in vivo
in the back of immunocompromised mice, revealing the impressive
capability to generate a better organized muscle-like tissue
compared to bulk hydrogels, and showing complete maturation, as
revealed by sarcomerogenesis and full myofiber striation (Fig. 7).
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.biomaterials.2017.03.026.
5. Conclusion
We have presented an innovative strategy for 3D printing bio-
mimetic constructs composed of unidirectionally aligned hydrogel
fibers loaded with muscle cell precursors (C2C12) in combination
Fig. 8. Multi-cellular 3D bioprinting through a microfluidic printing head. a) C2C12 myogenic precursors and BALB/3T3 fibroblasts were extruded with the same flow rates to
obtain a Janus-like compartmentalization within each laid hydrogel fiber. b) C2C12 and BALB/3T3 were respectively infected with GFP (green fluorescent) and mOrange (red
fluorescent) lentiviruses for optimal identification following 3D bioprinting. c) Compartmentalization of the two cell types was still retained after 5 days of culture. (For inter-
pretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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or not with fibroblasts (BALB/3T3). The 3D fabricated samples were
tested both in vitro and in vivo to evaluate their capability of sup-
portingmyogenesis and sarcomerogenesis. The results showed that
after 21 days of culture in vitro, C2C12 properly spread and fused
forming highly aligned long-range multinucleated myotubes, with
abundant and functional expression of myosin heavy chain (MHC)
and laminin (LAM). Besides, the 3D fabricated constructs when
grafted in vivo led to a substantial improvementdif compared to
bulk-hydrogel constructs used as controldof muscle-like archi-
tectural organization with the formation of tightly-packed, highly
parallel and completely striated myotube fibers. Interestingly, we
noticed that 3D bioprinted hydrogel fibers were partially degraded
during in vivo culture, and started being moderately substituted by
the arising myofibers.
Further exploration of multi-material/cellular deposition
through our microfluidic printing head will allow us to fabricate
more complex engineered constructs that might better recapitulate
the whole muscle histoarchitecture in vitro and in vivo, by
including, for example, microvascular networks. Further work will
also include the measurement of force generation during contrac-
tion under electrical and/or biochemical inducement.
In conclusion, we believe that the described results represent an
extraordinary advance in the field of skeletal muscle tissue engi-
neering, providing the chance, in a relatively near future, to
reconstruct missing, failing, or damaged muscles parts.
Acknowledgements
This work has been supported in part by grants from the Euro-
pean Research Council (ERC Advanced Grant # 322749/DEPTH to
G.C. and Starting Grant # 279647 to P.G.), by Grant #STRAT-
EGMED1/233224/10/NCBR/2014 [project START] to W.S., and by
Uncovering Excellence Grant 2014 [MDESMPLAT] and PRIN2015 #
2015FBNB5Y_002 to C.G.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.biomaterials.2017.03.026.
References
[1] M. Buckingham, D. Montarras, The origin and genetic regulation of myogenic
cells: from the embryo to the adult, in: Skelet. Muscle Repair Regen, Springer,
Netherlands, Dordrecht, n.d.: pp. 19e44. http://doi.org/10.1007/978-1-4020-
6768-6_2.
[2] D.J. Milner, J.A. Cameron, Muscle repair and regeneration: stem cells, scaffolds,
and the contributions of skeletal muscle to amphibian limb regeneration, Curr.
Top. Microbiol. Immunol. 367 (2013) 133e159, http://dx.doi.org/10.1007/82_
2012_292.
[3] J.G. Tidball, Mechanisms of muscle injury, repair, and regeneration, Compr.
Physiol. 1 (2011) 2029e2062, http://dx.doi.org/10.1002/cphy.c100092.
[4] P. Heher, B. Maleiner, J. Prüller, A.H. Teuschl, J. Kollmitzer, X. Monforte,
S. Wolbank, H. Redl, D. Rünzler, C. Fuchs, A novel bioreactor for the generation
of highly aligned 3D skeletal muscle-like constructs through orientation of
fibrin via application of static strain, Acta Biomater. 24 (2015) 251e265,
http://dx.doi.org/10.1016/j.actbio.2015.06.033.
[5] A. Ito, Y. Yamamoto, M. Sato, K. Ikeda, M. Yamamoto, H. Fujita, E. Nagamori,
Y. Kawabe, M. Kamihira, Induction of functional tissue-engineered skeletal
muscle constructs by defined electrical stimulation, Sci. Rep. 4 (2014) 4781,
http://dx.doi.org/10.1038/srep04781.
[6] L. Madden, M. Juhas, W.E. Kraus, G.A. Truskey, N. Bursac, Bioengineered hu-
man myobundles mimic clinical responses of skeletal muscle to drugs, Elife
2015 (2015) 1e14, http://dx.doi.org/10.7554/eLife.04885.
[7] C. Fuoco, R. Rizzi, A. Biondo, E. Longa, A. Mascaro, K. Shapira-Schweitzer,
O. Kossovar, S. Benedetti, M.L. Salvatori, S. Santoleri, S. Testa, S. Bernardini,
R. Bottinelli, C. Bearzi, S.M. Cannata, D. Seliktar, G. Cossu, C. Gargioli, In vivo
generation of a mature and functional artificial skeletal muscle, EMBO Mol.
Med. 7 (2015) 411e422, http://dx.doi.org/10.15252/emmm.201404062.
[8] M. Juhas, G.C. Engelmayr, A.N. Fontanella, G.M. Palmer, N. Bursac, Biomimetic
engineered muscle with capacity for vascular integration and functional
maturation in vivo, Proc. Natl. Acad. Sci. U. S. A. 111 (2014) 5508e5513, http://
dx.doi.org/10.1073/pnas.1402723111.
[9] H.H. Vandenburgh, S. Swasdison, P. Karlisch, Computer-aided mechano-
genesis of skeletal muscle organs from single cells in vitro, FASEB J. 5 (1991)
2860e2867. http://www.ncbi.nlm.nih.gov/pubmed/1916108.
[10] F.P.W. Melchels, M.A.N. Domingos, T.J. Klein, J. Malda, P.J. Bartolo,
D.W. Hutmacher, Additive manufacturing of tissues and organs, Prog. Polym.
Sci. 37 (2012) 1079e1104, http://dx.doi.org/10.1016/
j.progpolymsci.2011.11.007.
[11] M.M. Stanton, J. Samitier, S. S!anchez, Bioprinting of 3D hydrogels, Lab. Chip 15
(2015) 3111e3115, http://dx.doi.org/10.1039/C5LC90069G.
[12] F. Pati, J. Jang, D.-H. Ha, S. Won Kim, J.-W. Rhie, J.-H. Shim, D.-H. Kim, D.-
W. Cho, Printing three-dimensional tissue analogues with decellularized
extracellular matrix bioink, Nat. Commun. 5 (2014) 3935, http://dx.doi.org/
10.1038/ncomms4935.
[13] Y.-J. Choi, T.G. Kim, J. Jeong, H.-G. Yi, J.W. Park, W. Hwang, D.-W. Cho, 3D cell
printing of functional skeletal muscle constructs using skeletal muscle-
derived bioink, Adv. Healthc. Mater. (2016) 1e10, http://dx.doi.org/10.1002/
adhm.201600483.
[14] H.-W. Kang, S.J. Lee, I.K. Ko, C. Kengla, J.J. Yoo, A. Atala, A 3D bioprinting
system to produce human-scale tissue constructs with structural integrity,
Nat. Biotechnol. (2016), http://dx.doi.org/10.1038/nbt.3413.
[15] T.K. Merceron, M. Burt, Y.-J. Seol, H.-W. Kang, S.J. Lee, J.J. Yoo, A. Atala, A 3D
bioprinted complex structure for engineering the muscleetendon unit, Bio-
fabrication 7 (2015) 35003, http://dx.doi.org/10.1088/1758-5090/7/3/035003.
[16] L. Almany, D. Seliktar, Biosynthetic hydrogel scaffolds made from fibrinogen
and polyethylene glycol for 3D cell cultures, Biomaterials 26 (2005)
2467e2477, http://dx.doi.org/10.1016/j.biomaterials.2004.06.047.
[17] C. Colosi, S.R. Shin, V. Manoharan, S. Massa, M. Costantini, A. Barbetta,
M.R. Dokmeci, M. Dentini, A. Khademhosseini, Microfluidic bioprinting of
heterogeneous 3D tissue constructs using low-viscosity bioink, Adv. Mater. 28
(2016) 677e684, http://dx.doi.org/10.1002/adma.201503310.
[18] M. Costantini, J. Idaszek, K. Sz€oke, J. Jaroszewicz, M. Dentini, A. Barbetta,
J.E. Brinchmann, W. !Swie˛szkowski, 3D bioprinting of BM-MSCs-loaded ECM
biomimetic hydrogels for in vitro neocartilage formation, Biofabrication 8
(2016) 35002, http://dx.doi.org/10.1088/1758-5090/8/3/035002.
[19] J. Schindelin, C.T. Rueden, M.C. Hiner, K.W. Eliceiri, The ImageJ ecosystem: an
open platform for biomedical image analysis, Mol. Reprod. Dev. 82, (n.d.),
518e529. http://doi.org/10.1002/mrd.22489.
[20] R. Scardigli, C. Gargioli, D. Tosoni, U. Borello, M. Sampaolesi, C. Sciorati,
S. Cannata, E. Clementi, S. Brunelli, G. Cossu, Binding of sFRP-3 to EGF in the
extra-cellular space affects proliferation, differentiation and morphogenetic
events regulated by the two molecules, PLoS One 3 (2008) e2471, http://
dx.doi.org/10.1371/journal.pone.0002471.
[21] J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe,
F. Speleman, Accurate normalization of real-time quantitative RT-PCR data by
geometric averaging of multiple internal control genes, Genome Biol. 3
(2002). RESEARCH0034. http://www.ncbi.nlm.nih.gov/pubmed/12184808.
[22] C. Colosi, M. Costantini, A. Barbetta, R. Pecci, R. Bedini, M. Dentini, Morpho-
logical comparison of PVA scaffolds obtained by gas foaming and microfluidic
foaming techniques, Langmuir 29 (2013) 82e91, http://dx.doi.org/10.1021/
la303788z.
[23] R.R. Jose, M.J. Rodriquez, T.A. Dixon, F.G. Omenetto, D.L. Kaplan, Evolution of
bioinks and additive manufacturing technologies for 3D bioprinting, ACS
Biomater. Sci. Eng. 2 (2016) 1662e1678, http://dx.doi.org/10.1021/
acsbiomaterials.6b00088.
[24] J. Malda, J. Visser, F.P. Melchels, T. Jüngst, W.E. Hennink, W.J.A. Dhert, J. Groll,
D.W. Hutmacher, 25th anniversary article: engineering hydrogels for bio-
fabrication, Adv. Mater. 25 (2013) 5011e5028, http://dx.doi.org/10.1002/
adma.201302042.
[25] C. Colosi, M. Costantini, R. Latini, S. Ciccarelli, A. Stampella, A. Barbetta,
M. Massimi, L. Conti Devirgiliis, M. Dentini, Rapid prototyping of chitosan-
coated alginate scaffolds through the use of a 3D fiber deposition technique,
J. Mater. Chem. B 2 (2014) 6779e6791, http://dx.doi.org/10.1039/
C4TB00732H.
[26] R. Lapasin, S. Pricl, Rheology of Industrial Polysaccharides: Theory and Ap-
plications, Springer, US, Boston, MA, 1995, http://dx.doi.org/10.1007/978-1-
4615-2185-3.
[27] L.E. Bertassoni, J.C. Cardoso, V. Manoharan, A.L. Cristino, N.S. Bhise,
W.A. Araujo, P. Zorlutuna, N.E. Vrana, A.M. Ghaemmaghami, M.R. Dokmeci,
A. Khademhosseini, Direct-write bioprinting of cell-laden methacrylated
gelatin hydrogels, Biofabrication 6 (2014) 24105, http://dx.doi.org/10.1088/
1758-5082/6/2/024105.
[28] L. Sun, S.T. Parker, D. Syoji, X. Wang, J.A. Lewis, D.L. Kaplan, Direct-Write as-
sembly of 3D silk/hydroxyapatite scaffolds for bone Co-Cultures, Adv. Healthc.
Mater. 1 (2012) 729e735, http://dx.doi.org/10.1002/adhm.201200057.
[29] K. Tanaka, K. Sato, T. Yoshida, T. Fukuda, K. Hanamura, N. Kojima, T. Shirao,
T. Yanagawa, H. Watanabe, Evidence for cell density affecting C2C12 myo-
genesis: possible regulation of myogenesis by cell-cell communication,
Muscle Nerve 44 (2011) 968e977, http://dx.doi.org/10.1002/mus.22224.
[30] A.J. Engler, M.A. Griffin, S. Sen, C.G. B€onnemann, H.L. Sweeney, D.E. Discher,
Myotubes differentiate optimally on substrates with tissue-like stiffness:
pathological implications for soft or stiff microenvironments, J. Cell Biol. 166
(2004) 877e887, http://dx.doi.org/10.1083/jcb.200405004.
[31] A.J. Engler, S. Sen, H.L. Sweeney, D.E. Discher, Matrix elasticity directs stem cell
lineage specification, Cell 126 (2006) 677e689, http://dx.doi.org/10.1016/
M. Costantini et al. / Biomaterials 131 (2017) 98e110 109
j.cell.2006.06.044.
[32] C. Fuoco, M.L. Salvatori, A. Biondo, K. Shapira-Schweitzer, S. Santoleri,
S. Antonini, S. Bernardini, F.S. Tedesco, S. Cannata, D. Seliktar, G. Cossu,
C. Gargioli, Injectable polyethylene glycol-fibrinogen hydrogel adjuvant im-
proves survival and differentiation of transplanted mesoangioblasts in acute
and chronic skeletal-muscle degeneration, Skelet. Muscle 2 (2012) 24, http://
dx.doi.org/10.1186/2044-5040-2-24.
[33] S.T. Cooper, A.L. Maxwell, E. Kizana, M. Ghoddusi, E.C. Hardeman,
I.E. Alexander, D.G. Allen, K.N. North, C2C12 co-culture on a fibroblast sub-
stratum enables sustained survival of contractile, highly differentiated myo-
tubes with peripheral nuclei and adult fast myosin expression, Cell Motil.
Cytoskelet. 58 (2004) 200e211, http://dx.doi.org/10.1002/cm.20010.
[34] I.Y. Shadrin, A. Khodabukus, N. Bursac, Striated muscle function, regeneration,
and repair, Cell. Mol. Life Sci. 73 (2016) 4175e4202, http://dx.doi.org/
10.1007/s00018-016-2285-z.
[35] C. Fuoco, L.L. Petrilli, S. Cannata, C. Gargioli, Matrix scaffolding for stem cell
guidance toward skeletal muscle tissue engineering, J. Orthop. Surg. Res. 11
(2016) 86, http://dx.doi.org/10.1186/s13018-016-0421-y.
[36] C. Fuoco, S. Cannata, C. Gargioli, Could a functional artificial skeletal muscle be
useful in muscle wasting? Curr. Opin. Clin. Nutr. Metab. Care 19 (2016)
182e187, http://dx.doi.org/10.1097/MCO.0000000000000271.
[37] B.M. Sicari, J.P. Rubin, C.L. Dearth, M.T. Wolf, F. Ambrosio, M. Boninger,
N.J. Turner, D.J. Weber, T.W. Simpson, A. Wyse, E.H.P. Brown, J.L. Dziki,
L.E. Fisher, S. Brown, S.F. Badylak, An acellular biologic scaffold promotes
skeletal muscle formation in mice and humans with volumetric muscle loss,
Sci. Transl. Med. 6 (2014) 234ra58, http://dx.doi.org/10.1126/
scitranslmed.3008085.
[38] M.A. Machingal, B.T. Corona, T.J. Walters, V. Kesireddy, C.N. Koval,
A. Dannahower, W. Zhao, J.J. Yoo, G.J. Christ, A tissue-engineered muscle
repair construct for functional restoration of an irrecoverable muscle injury in
a murine model, Tissue Eng. Part A 17 (2011) 2291e2303, http://dx.doi.org/
10.1089/ten.TEA.2010.0682.
[39] S. Levenberg, J. Rouwkema, M. Macdonald, E.S. Garfein, D.S. Kohane,
D.C. Darland, R. Marini, C.A. van Blitterswijk, R.C. Mulligan, P.A. D'Amore,
R. Langer, Engineering vascularized skeletal muscle tissue, Nat. Biotechnol. 23
(2005) 879e884, http://dx.doi.org/10.1038/nbt1109.
[40] P. Heher, B. Maleiner, J. Prüller, A.H. Teuschl, J. Kollmitzer, X. Monforte,
S. Wolbank, H. Redl, D. Rünzler, C. Fuchs, A novel bioreactor for the generation
of highly aligned 3D skeletal muscle-like constructs through orientation of
fibrin via application of static strain, Acta Biomater. 24 (2015) 251e265,
http://dx.doi.org/10.1016/j.actbio.2015.06.033.
[41] M. Juhas, G.C. Engelmayr, A.N. Fontanella, G.M. Palmer, N. Bursac, Biomimetic
engineered muscle with capacity for vascular integration and functional
maturation in vivo, Proc. Natl. Acad. Sci. U. S. A. 111 (2014) 5508e5513, http://
dx.doi.org/10.1073/pnas.1402723111.
[42] S.V. Murphy, A. Atala, 3D bioprinting of tissues and organs, Nat. Biotechnol. 32
(2014) 773e785, http://dx.doi.org/10.1038/nbt.2958.
[43] V. Mironov, V. Kasyanov, C. Drake, R.R. Markwald, Organ printing: promises
and challenges, Regen. Med. 3 (2008) 93e103, http://dx.doi.org/10.2217/
17460751.3.1.93.
[44] C. Fuoco, E. Sangalli, R. Vono, S. Testa, B. Sacchetti, M.V.G. Latronico,
S. Bernardini, P. Madeddu, G. Cesareni, D. Seliktar, R. Rizzi, C. Bearzi,
S.M. Cannata, G. Spinetti, C. Gargioli, 3D hydrogel environment rejuvenates
aged pericytes for skeletal muscle tissue engineering, Front. Physiol. 5 (2014)
203, http://dx.doi.org/10.3389/fphys.2014.00203.
[45] P. Kerscher, I.C. Turnbull, A.J. Hodge, J. Kim, D. Seliktar, C.J. Easley, K.D. Costa,
E.A. Lipke, Direct hydrogel encapsulation of pluripotent stem cells enables
ontomimetic differentiation and growth of engineered human heart tissues,
Biomaterials 83 (2016) 383e395, http://dx.doi.org/10.1016/
j.biomaterials.2015.12.011.
[46] K. Shapira-Schweitzer, M. Habib, L. Gepstein, D. Seliktar,
A photopolymerizable hydrogel for 3-D culture of human embryonic stem
cell-derived cardiomyocytes and rat neonatal cardiac cells, J. Mol. Cell. Cardiol.
46 (2009) 213e224, http://dx.doi.org/10.1016/j.yjmcc.2008.10.018.
[47] M. Centola, F. Abbruzzese, C. Scotti, A. Barbero, G. Vadal!a, V. Denaro, I. Martin,
M. Trombetta, A. Rainer, A. Marsano, Scaffold-based delivery of a clinically
relevant anti-angiogenic drug promotes the formation of in vivo stable
cartilage, Tissue Eng. Part A 19 (2013) 1960e1971, http://dx.doi.org/10.1089/
ten.tea.2012.0455.
[48] J. Choi, O.C. Kwon, W. Jo, H.J. Lee, M.W. Moon, 4D printing technology: a re-
view, 3d Print. Addit. Manuf. 2 (2015) 159e167, http://dx.doi.org/10.1089/
3dp.2015.0039.
M. Costantini et al. / Biomaterials 131 (2017) 98e110110
